发明名称 |
COMBINATION PRODUCTS FOR TREATING CANCER |
摘要 |
The present invention concerns products containing (i) at least one nucleic acid sequence coding for the human somatostatin 2 receptor protein (sst2) having the sequence SEQ ID NO:1, ortholog or derivative thereof, (ii) at least one nucleic acid sequence coding for the human deoxycytidine kinase protein (dck) having the sequence SEQ ID NO:2, ortholog or derivative thereof, (iii) at least one nucleic acid sequence coding for the human uridine monophosphate kinase protein (umk) having the sequence SEQ ID NO:3 ortholog or derivative thereof, and (iv) gemcitabine, as a combined preparation for simultaneous, separate, or sequential use for treating cancer in a subject. |
申请公布号 |
EP2209484(A1) |
申请公布日期 |
2010.07.28 |
申请号 |
EP20080844792 |
申请日期 |
2008.10.10 |
申请人 |
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM);CAYLA |
发明人 |
BUSCAIL, LOUIS;TIRABY, GERARD;VERNEJOUL, FABIENNE;SUSINI, CHRISTIANE;DROCOURT, DANIEL |
分类号 |
A61K38/17;A61K31/7068;A61K38/45;A61P35/00;C12N15/63 |
主分类号 |
A61K38/17 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|